Patent · US Active

Methods of assessing risk of developing a severe response to coronavirus infection

US11257569B1 · kind B1 · utility

0Cited by

10References

6Claims

0Family size

Assignee

Genetic Technologies Limited · AU

Inventors

Gillian Sue Dite · Melbourne, AU
Nicholas Mark Murphy · Melbourne, AU
Richard Allman · Melton, AU

Key dates

Filing date	Jul 6, 2021
Grant date	Feb 22, 2022
Priority date	—
Expiry date	Jul 6, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/158
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

The present disclosure relates to methods and systems for assessing the risk of a human subject developing a severe response to a Coronavirus infection, such as a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.